Johnson & Johnson vs. Xeris Biopharma Holdings, Inc. Common Stock
JNJ
Johnson & Johnson
$272.32 -1.45%
VS XERSXeris Biopharma Holdings, Inc. Common Stock
$10.20 -6.08%
Johnson & Johnson and Xeris Biopharma Holdings, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | XERS | |
|---|---|---|
| Market Cap | $665.19 billion | $1.98 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | XERS | |
|---|---|---|
| Dividend Yield | 1.97% | — |
JNJ and XERS split the dividend factors evenly.
Risk & Sentiment
| JNJ | XERS | |
|---|---|---|
| Short Interest | 0.67% | 0.10% |
XERS leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, XERS overview, XERS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.